Miromatrix Medical Inc.
MIRO · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $35,781 | $47,689 | $37,814 | $62,513 |
| - Cash | $6,116 | $4,572 | $13,620 | $5,208 |
| + Debt | $3,223 | $3,330 | $3,442 | $3,552 |
| Enterprise Value | $32,888 | $46,447 | $27,636 | $60,857 |
| Revenue | $11 | $9 | $8 | $930 |
| % Growth | 31.2% | 6.7% | -99.1% | – |
| Gross Profit | -$114 | -$116 | -$117 | $805 |
| % Margin | -1,018.5% | -1,367.7% | -1,466.2% | 86.6% |
| EBITDA | -$6,150 | -$6,233 | -$6,841 | -$6,933 |
| % Margin | -55,031.4% | -73,180.8% | -85,713.4% | -745.2% |
| Net Income | -$6,454 | -$6,530 | -$7,190 | -$6,946 |
| % Margin | -57,746% | -76,675.1% | -90,091.8% | -746.6% |
| EPS Diluted | -0.24 | -0.24 | -0.32 | -0.33 |
| % Growth | 0% | 25% | 3% | – |
| Operating Cash Flow | -$4,572 | -$5,068 | -$8,616 | -$6,055 |
| Capital Expenditures | $0 | -$17 | -$16 | -$207 |
| Free Cash Flow | -$4,572 | -$5,085 | -$8,632 | -$6,262 |